Access the full text.
Sign up today, get DeepDyve free for 14 days.
Yongjie Wei, S. Pattingre, Sangita Sinha, M. Bassik, B. Levine (2008)
JNK1-mediated phosphorylation of Bcl-2 regulates starvation-induced autophagy.Molecular cell, 30 6
B. Dwarakanath, V. Jain (2009)
Targeting glucose metabolism with 2-deoxy-D-glucose for improving cancer therapy.Future oncology, 5 5
A. Giammarioli, L. Gambardella, C. Barbati, D. Pietraforte, A. Tinari, Manuela Alberton, L. Gnessi, R. Griffin, M. Minetti, W. Malorni (2012)
Differential effects of the glycolysis inhibitor 2‐deoxy‐D‐glucose on the activity of pro‐apoptotic agents in metastatic melanoma cells, and induction of a cytoprotective autophagic responseInternational Journal of Cancer, 131
Z. Zhelev, D. Ivanova, I. Aoki, T. Saga, R. Bakalova (2015)
2-Deoxy-D-glucose Sensitizes Cancer Cells to Barasertib and Everolimus by ROS-independent Mechanism(s).Anticancer research, 35 12
A. Jemal, F. Bray, Melissa Center, J. Ferlay, Elizabeth Ward, David Forman (2011)
Global Cancer Statistics
J. Thorburn, Z. Andrysik, Leah Staskiewicz, Jacob Gump, P. Maycotte, A. Oberst, D. Green, J. Espinosa, A. Thorburn (2014)
Autophagy controls the kinetics and extent of mitochondrial apoptosis by regulating PUMA levels.Cell reports, 7 1
Maike Laussmann, E. Passante, C. Hellwig, B. Tomiczek, L. Flanagan, J. Prehn, H. Huber, M. Rehm (2012)
Proteasome Inhibition Can Impair Caspase-8 Activation upon Submaximal Stimulation of Apoptotic Tumor Necrosis Factor-related Apoptosis Inducing Ligand (TRAIL) Signaling*The Journal of Biological Chemistry, 287
T. O'Donovan, G. O'sullivan, S. McKenna (2011)
Induction of autophagy by drug-resistant esophageal cancer cells promotes their survival and recovery following treatment with chemotherapeutics.Autophagy, 7
R. Aft, R. Aft, Fanjie Zhang, D. Gius (2002)
Evaluation of 2-deoxy-D-glucose as a chemotherapeutic agent: mechanism of cell deathBritish Journal of Cancer, 87
Kyung-Jin Park, Seung-Hyun Lee, Chang-Han Lee, Ji-young Jang, Junho Chung, M. Kwon, Yong-Sung Kim (2009)
Upregulation of Beclin-1 expression and phosphorylation of Bcl-2 and p53 are involved in the JNK-mediated autophagic cell death.Biochemical and biophysical research communications, 382 4
Weiyang He, Qiong Wang, Jennings Xu, Xiuling Xu, M. Padilla, G. Ren, X. Gou, Y. Lin (2012)
Attenuation of TNFSF10/TRAIL-induced apoptosis by an autophagic survival pathway involving TRAF2- and RIPK1/RIP1-mediated MAPK8/JNK activationAutophagy, 8
(2010)
and apoptosis
N. Mizushima, M. Komatsu (2011)
Autophagy: Renovation of Cells and TissuesCell, 147
Ling Xu, X. Qu, Ye Zhang, Xuejun Hu, Xiang-Hong Yang, K. Hou, Y. Teng, Jingdong Zhang, K. Sada, Yunpeng Liu (2009)
Oxaliplatin enhances TRAIL‐induced apoptosis in gastric cancer cells by CBL‐regulated death receptor redistribution in lipid raftsFEBS Letters, 583
Xu Di, Guofeng Zhang, Yaqin Zhang, K. Takeda, L. Rosado, Baolin Zhang (2013)
Accumulation of autophagosomes in breast cancer cells induces TRAIL resistance through downregulation of surface expression of death receptors 4 and 5Oncotarget, 4
Neha Kaushik, Su Lee, T. Choi, K. Baik, H. Uhm, Chung Kim, N. Kaushik, E. Choi (2015)
Non-thermal plasma with 2-deoxy-D-glucose synergistically induces cell death by targeting glycolysis in blood cancer cellsScientific Reports, 5
G. Pan, K. O’Rourke, A. Chinnaiyan, R. Gentz, R. Ebner, Jian Ni, V. Dixit (1997)
The Receptor for the Cytotoxic Ligand TRAIL, 276
Y. Zhao, E. Butler, M. Tan (2013)
Targeting cellular metabolism to improve cancer therapeuticsCell Death & Disease, 4
Y Zhao, EB Butler, M Tan (2013)
Targeting glucose metabolism with 2-deoxy-D-glucose for improving cancer therapyCell Death Dis, 4
J. Soria, Z. Márk, P. Zatloukal, B. Szima, I. Albert, E. Juhász, J. Pujol, J. Kozielski, N. Baker, D. Smethurst, Y. Hei, A. Ashkenazi, H. Stern, L. Amler, Yang Pan, F. Blackhall (2011)
Randomized phase II study of dulanermin in combination with paclitaxel, carboplatin, and bevacizumab in advanced non-small-cell lung cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 29 33
W Hou, J Han, C Lu, LA Goldstein, H Rabinowich (2010)
Autophagic degradation of active caspase-8: a crosstalk mechanism between autophagy and apoptosisAutophagy, 6
W. Hou, Jie Han, Caisheng Lu, L. Goldstein, H. Rabinowich (2010)
Autophagic degradation of active caspase-8Autophagy, 6
S. Pattingre, Amina Tassa, X. Qu, R. Garuti, X. Liang, N. Mizushima, M. Packer, M. Schneider, B. Levine (2005)
Bcl-2 Antiapoptotic Proteins Inhibit Beclin 1-Dependent AutophagyCell, 122
Hao Liu, C. Jiang, C. Lavis, A. Croft, Li Dong, Hsin-Yi Tseng, Fan Yang, K. Tay, P. Hersey, Xu Zhang (2009)
2-Deoxy-D-glucose enhances TRAIL-induced apoptosis in human melanoma cells through XBP-1-mediated up-regulation of TRAIL-R2Molecular Cancer, 8
Zi Li, Xiuling Xu, L. Bai, Wenshu Chen, Y. Lin (2011)
Epidermal Growth Factor Receptor-mediated Tissue Transglutaminase Overexpression Couples Acquired Tumor Necrosis Factor-related Apoptosis-inducing Ligand Resistance and Migration through c-FLIP and MMP-9 Proteins in Lung Cancer Cells*The Journal of Biological Chemistry, 286
Sandra-Annika Quast, K. Steinhorst, M. Plötz, J. Eberle (2015)
Sensitization of Melanoma Cells for Death Ligand TRAIL Is Based on Cell Cycle Arrest, ROS Production, and Activation of Proapoptotic Bcl-2 Proteins.The Journal of investigative dermatology, 135 11
Dan-dan Li, Lei Wang, R. Deng, Jun Tang, Y. Shen, J. Guo, Ying Wang, liangjiang xia, Guo Feng, Qiang Liu, Wenlin Huang, Yitong Zeng, Xiao-Feng Zhu (2009)
The pivotal role of c-Jun NH2-terminal kinase-mediated Beclin 1 expression during anticancer agents-induced autophagy in cancer cellsOncogene, 28
DR Camidge, RS Herbst, MS Gordon, SG Eckhardt, R Kurzrock, B Durbin, J Ing, TM Tohnya, J Sager, A Ashkenazi, G Bray, D Mendelson (2010)
A phase I safety and pharmacokinetic study of the death receptor 5 agonistic antibody PRO95780 in patients with advanced malignancies. Clinical cancer researchOff J Am Assoc Cancer Res, 16
Lindsey Torre, F. Bray, R. Siegel, J. Ferlay, J. Lortet-Tieulent, A. Jemal (2015)
Global cancer statistics, 2012CA: A Cancer Journal for Clinicians, 65
B. Kurbanov, L. Fecker, C. Geilen, W. Sterry, J. Eberle (2007)
Resistance of melanoma cells to TRAIL does not result from upregulation of antiapoptotic proteins by NF-κB but is related to downregulation of initiator caspases and DR4Oncogene, 26
D. Camidge, R. Herbst, M. Gordon, S. Eckhardt, R. Kurzrock, B. Durbin, J. Ing, T. Tohnya, J. Sager, A. Ashkenazi, G. Bray, D. Mendelson (2010)
A Phase I Safety and Pharmacokinetic Study of the Death Receptor 5 Agonistic Antibody PRO95780 in Patients with Advanced MalignanciesClinical Cancer Research, 16
R. Mora, Anette Abschuetz, Tim Kees, I. Dokic, N. Joschko, S. Kleber, R. Geibig, Eric Mosconi, H. Zentgraf, A. Martin-Villalba, A. Régnier-Vigouroux (2009)
TNF‐α‐ and TRAIL‐resistant glioma cells undergo autophagy‐dependent cell death induced by activated microgliaGlia, 57
Purpose TNF-related apoptosis-inducing ligand (TRAIL) resistance significantly limits its use in clinical practice. It has been reported that 2-deoxy-d -glucose (2-DG) can enhance TRAIL’s cytotoxicity. Our studies were designed to investigate the mechanisms of 2-DG reversing TRAIL resistance therapy in gastric cancer cells. Methods Gastric cancer cells (MGC803, SGC7901) were treated with 2-DG and TRAIL. Cell viability was determined by CCK-8 assay and detection of apoptosis by flow cytometry. Autophagic and apoptosis protein expression and c-Jun NH2- terminal kinase (JNK) phosphorylation were determined by Western blotting. Autophagy response and JNK activities were inhibited by specific inhibitor, 3MA or SP600125, respectively. LDH release assay was used to detect cytotoxicity. Results We confirmed that TRAIL triggered an autophagic response in TRAIL-resistant gastric cancer cells, MGC803 and SGC7901, and depended on JNK activation. Blocking autophagy or JNK activation with specific inhibitor, 3MA or SP600125, potentiated cell death and caspase-3 activation. Furthermore, we confirmed that 2-DG inhibited the viability of gastric cancer cells, phosphorylation of JNK induced by TRAIL and increased gastric cancer cells to TRAIL-induced apoptosis. Conclusions Taken together, we show that 2-DG can sensitize TRAIL-induced apoptosis, at least in part, through suppress- ing JNK-mediated cytoprotective autophagic signaling in MGC803 and SGC7901cells.
Cancer Chemotherapy and Pharmacology – Springer Journals
Published: Jan 31, 2018
Access the full text.
Sign up today, get DeepDyve free for 14 days.